University of Copenhagen

Sykehuset Ostfold Hf

Norges Miljo-Og Biovitenskapelige Universitet (Nmbu)

Norges Miljo-Og Blovitenskapelige Universitet (Nmbu)

Norges Miljø - Og Biovitenskapelige Universitet (Nmbu)

Sykehuset Østfold Hf

Tor Lea

Karsten Kristiansen

Ida Sogaard Larsen

Jacob Bak Holm

Charlotte Kleiveland

Morten Jacobsen

Benjamin Anderschou Holbech Jensen

Ida Søgaard Larsen

Described is a method for the treatment or prevention of GI tract dysbiosis in a subject, said method including administering an effective amount of a non-viableor a lysate ofto said subject. The invention further provides a method for the treatment or prevention of a disease or condition selected from small intestine bacterial overgrowth (SIBO), small intestine fungal overgrowth syndrome (SIFO), GI tract cancers, breast cancer, neurological disorders, malnutrition, chronic fatigue syndrome, autism, cardiovascular diseases and GI tract infections in a subject with GI tract dysbiosis, said method including administering an effective amount of a non-viableor a lysate ofto said subject. A non-viableor a lysate offor use in said methods is further provided.

Treatment or prevention of gastrointestinal dysbiosis

The invention provides a method for the treatment or prevention of GI tract dysbiosis in a subject, said method comprising administering an effective amount of a non-viableor a lysate ofto said subject. The invention further provides a method for the treatment or prevention of a disease or condition selected from small intestine bacterial overgrowth (SIBO), small intestine fungal overgrowth syndrome (SIFO), GI tract cancers, breast cancer, neurological disorders, malnutrition, chronic fatigue syndrome, autism, cardiovascular diseases and GI tract infections in a subject with GI tract dysbiosis, said method comprising administering an effective amount of a non-viableor a lysate ofto said subject. A non-viableor a lysate offor use in said methods is further provided.

Growing community of inventors

Oslo, Norway

Tor Lea